ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 93 filers reported holding ADURO BIOTECH INC in Q3 2016. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $15,000 | -58.3% | 14,195 | -39.2% | 0.00% | – |
Q2 2019 | $36,000 | -81.6% | 23,332 | -52.5% | 0.00% | -100.0% |
Q1 2019 | $196,000 | -37.8% | 49,135 | -58.9% | 0.00% | -33.3% |
Q4 2018 | $315,000 | -7.9% | 119,416 | +156.6% | 0.00% | +50.0% |
Q3 2018 | $342,000 | +280.0% | 46,532 | +263.5% | 0.00% | +100.0% |
Q2 2018 | $90,000 | -80.4% | 12,800 | -68.5% | 0.00% | -50.0% |
Q2 2016 | $460,000 | +8.5% | 40,668 | +22.9% | 0.00% | 0.0% |
Q1 2016 | $424,000 | -42.3% | 33,100 | +26.8% | 0.00% | -50.0% |
Q4 2015 | $735,000 | – | 26,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |